C-type natriuretic peptide (CNP) antibody and antigen (Recombinant protein)
Diagnostic C-type natriuretic peptide (CNP) antibodies (anti-C-type natriuretic peptide, anti-CNP) and antigens (recombinant C-type natriuretic peptide (CNP) protein) for Cardiovascular disease CNP detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-CNP-Ag01 | Recombinant human CNP Protein | 3090 |
GMP-h-CNP-Ab01 | Anti-human CNP mouse monoclonal antibody (mAb) | 1953 |
GMP-h-CNP-Ab02 | Anti-human CNP mouse monoclonal antibody (mAb) | 1953 |
GMP-h-CNP-Ab03 | Anti-human CNP human monoclonal antibody (mAb) | 1953 |
GMP-h-CNP-Ab04 | Anti-human CNP human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-CNP-Ag01 |
Product Name | Recombinant human CNP Protein |
Target/Biomarker | C-type natriuretic peptide (CNP) |
Alias of Target/Biomarker | CNP1, HLD20 |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | C-type natriuretic peptide (CNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CNP level test of Cardiovascular disease (cardiovascular disease) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human CNP Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-CNP-Ab01, GMP-h-CNP-Ab02 |
Product Name | Anti-human CNP mouse monoclonal antibody (mAb) |
Target/Biomarker | C-type natriuretic peptide (CNP) |
Alias of Target/Biomarker | CNP1, HLD20 |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | C-type natriuretic peptide (CNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CNP level test of Cardiovascular disease (cardiovascular disease) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human CNP mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-CNP-Ab03, GMP-h-CNP-Ab04 |
Product Name | Anti-human CNP human monoclonal antibody (mAb) |
Target/Biomarker | C-type natriuretic peptide (CNP) |
Alias of Target/Biomarker | CNP1, HLD20 |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | C-type natriuretic peptide (CNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CNP level test of Cardiovascular disease (cardiovascular disease) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human CNP human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
The natriuretic peptide system comprises three structurally related peptides: atrial natriuretic peptide, B-type natriuretic peptide and C-type natriuretic peptide. In circulation, they play an important endocrine role in the regulation of cardiovascular homeostasis by maintaining blood pressure and extracellular fluid volume. Atrial natriuretic peptide, B-type natriuretic peptide and C-type natriuretic peptide have gained considerable diagnostic interest as biomarkers in cardiovascular disease.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments